Monetary Cost of Alzheimer's Disease in China

NCT02694445 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3098

Last updated 2020-05-12

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to estimate the Chinese economic burden in patients with Alzheimer's Disease (AD).

Conditions

Interventions

OTHER

observation

The study is non-interventional.

Sponsors & Collaborators

  • Chinese Medical Doctor Association

    collaborator OTHER
  • Beijing Friendship Hospital

    lead OTHER

Principal Investigators

  • Jia Jianping, Doctor · Head of Neurology Department, Capital Medical University

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-03-31
Completion
2016-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02694445 on ClinicalTrials.gov